Analysts Set Globe Life Inc. (NYSE:GL) Target Price at $191.67

Globe Life Inc. (NYSE:GLGet Free Report) has been assigned an average rating of “Moderate Buy” from the eleven ratings firms that are currently covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation, eight have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year target price among brokerages that have issued a report on the stock in the last year is $191.6667.

GL has been the topic of several research analyst reports. Jefferies Financial Group upped their price objective on shares of Globe Life from $147.00 to $166.00 and gave the stock a “hold” rating in a research report on Friday, July 10th. JPMorgan Chase & Co. boosted their target price on Globe Life from $181.00 to $201.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 21st. Piper Sandler upped their target price on Globe Life from $175.00 to $200.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 15th. Morgan Stanley increased their price target on shares of Globe Life from $181.00 to $208.00 and gave the company an “overweight” rating in a research report on Monday, July 6th. Finally, Weiss Ratings lowered shares of Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a report on Monday, July 20th.

View Our Latest Research Report on GL

Insider Buying and Selling at Globe Life

In other Globe Life news, CEO Frank M. Svoboda sold 10,000 shares of the company’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $166.68, for a total value of $1,666,800.00. Following the completion of the transaction, the chief executive officer directly owned 54,020 shares in the company, valued at approximately $9,004,053.60. This represents a 15.62% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Thomas Peter Kalmbach sold 25,650 shares of Globe Life stock in a transaction dated Tuesday, July 28th. The shares were sold at an average price of $178.58, for a total transaction of $4,580,577.00. Following the sale, the chief financial officer directly owned 50,568 shares in the company, valued at $9,030,433.44. The trade was a 33.65% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 151,908 shares of company stock worth $27,239,981 over the last three months. 2.11% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. CYBER HORNET ETFs LLC bought a new stake in shares of Globe Life in the 2nd quarter worth approximately $28,000. Hilton Head Capital Partners LLC purchased a new stake in shares of Globe Life in the 4th quarter worth approximately $30,000. MUFG Securities EMEA plc bought a new position in Globe Life during the 2nd quarter valued at approximately $31,000. Torren Management LLC bought a new position in Globe Life during the 4th quarter valued at approximately $37,000. Finally, Johnson Financial Group Inc. purchased a new position in Globe Life during the second quarter valued at $39,000. Hedge funds and other institutional investors own 81.61% of the company’s stock.

Globe Life Price Performance

Shares of NYSE:GL opened at $172.44 on Friday. Globe Life has a fifty-two week low of $127.85 and a fifty-two week high of $191.55. The company’s 50-day moving average is $178.54 and its 200 day moving average is $159.03. The company has a market capitalization of $13.25 billion, a P/E ratio of 11.45 and a beta of 0.48. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.07 and a current ratio of 0.07.

Globe Life (NYSE:GLGet Free Report) last announced its quarterly earnings data on Wednesday, July 22nd. The company reported $3.61 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.67 by ($0.06). The firm had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.59 billion. Globe Life had a net margin of 19.58% and a return on equity of 20.52%. The company’s revenue was up 8.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $3.05 earnings per share. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. On average, equities research analysts forecast that Globe Life will post 15.71 earnings per share for the current year.

Globe Life Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Monday, October 5th will be issued a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Monday, October 5th. Globe Life’s dividend payout ratio is currently 8.76%.

Globe Life announced that its board has initiated a stock buyback program on Monday, August 10th that allows the company to repurchase $2.50 billion in outstanding shares. This repurchase authorization allows the company to purchase up to 17.7% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company’s board of directors believes its shares are undervalued.

About Globe Life

(Get Free Report)

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.

Featured Stories

Analyst Recommendations for Globe Life (NYSE:GL)

Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.